временное руководство, 13 мая 2020 г.
Целью настоящего документа является предоставле- ние временных рекомендаций по биологической без- опасности в лабораторных усл...виях, которые следует соблюдать при исследовании клинических образцов пациентов, подпадающих под определение случаев ин- фицирования новым патогеном, выявленным в Ухане, Китай, то есть коронавирусным заболеванием 2019 г. COVID-19.
more
Basic psychosocial support skills are at the core of any Mental Health and PsychosocialSupport (MHPSS) intervention. Such skills are also indispensable for many others involvedin the COVID-19 response, whether they identify as an MHPSS provider or not. Thus, this guide is meant for all COVID-19 resp...onders.
It is available in different languages: English, French, Spanish, Arabic, Amharic, Greek, Chinese, Bahasa Indonesia, Russian
more
La presente guía contiene recomendaciones sobre prácticas y estrategias en materia de salud y seguridad para la prevención de la COVID-19, basadas en materiales desarrollados por muchas organizaciones de todo el mundo.
Ce guide a été préparé par le Bureau des activités pour les employeurs (ACT/EMP) de l’Organisation internationale du Travail et contient des recommandations sur les mesures pratiques et les méthodes à mettre en oeuvre en matière de santé et de sécurité pour la prévention du COVID-19.
Primary care health centers and providers who care for individuals with hypertension and cardiovascular disease have an important role to play in ensuring continued access to care, reducing the risk of coronavirus infection, and appropriately managing people with these co-morbidities who acquire COV...ID-19. This guidance includes these considerations
more
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...ial Medicines 2019; based on clinical presentations and symptoms identified and prioritized in World Health Organization (WHO) and Surviving Sepsis Campaign (SSC) guidelines and the evidence presented in these guidelines.
more
The Lancet DOI: 10.1016/S0140-6736(20)31053-9
COVID-19: Travel, Points of Entry and Border Health
The COVID-19 pandemic poses an additional and critical challenge in a fragile humanitarian context, where the population is already highly vulnerable and lives in often overcrowded settlements where distancing is impossible, and with limited access to basic health services and hygiene. Further sprea...d of COVID-19 in the EHoA region will burden the already complex humanitarian situation with devastating consequences.
more
Over nine years of protracted and violent conflict in Syria has decimated its health system,killed an estimated 586,000 people and forcibly displaced more than half the 22 million pre-war population from their homes. As of June 2020, a total of 6.2 million Syrians (of whom 40% are children) are inte...rnally displaced (IDPs) and 5.5 million are refugees. Over half of Syria’s population (11.7 million) are in-need of humanitarian aid across the whole of Syria
more
It is targeted towards humanitarian settings and aims to complement other guidance on the management of the dead with a stronger focus on the practical realities faced when dealing with the dead in humanitarian settings. The guidance offers practical recommendations for the management of the bodies ...or human remains of persons who died from COVID-19
more
Going to work during this COVID-19 pandemic has placed frontline workers under immense and unprecedented pressure, putting their physical, mental and social well-being at risk. Exposure to excessive stress, for prolonged periods can have many harmful consequences on the emotional and mental well-bei...ng of frontline workers. This document outlines some actions that frontline workers can take to cope with stress and take care of themselves during COVID-19.
more
Available in Englisch, Spanish and Portuguese
5 Nov. 2020
The policy brief provides a concise summary of information and considerations to ensure optimal management of influenza during the COVID-19 pandemic. It includes a list of technical guidance and other resources to assist policy makers with monitoring the situation, preventing seasonal i...nfluenza, reducing severe complications and mortality, protecting specific populations and communicating to and engaging with the public.
more
Данный документ служит ориентиром для органов общественного здравоохранения по реагированию
на COVID-19 на национальном и региональном уровнях и вносит актуальные ...бновления в глобальную стратегию
реагирования на пандемию COVID-19. Данный документ дополняет технические рекомендации по обеспечению
готовности и реагированию на COVID-19, опубликованные ВОЗ со времени начала принятия мер, и содержит ссылки
на них.
Updated fighting strategy aigainst Covid-19
more
Этот документ представляет собой обновление
рекомендаций «Уход на дому за пациентами с легкой
формой заболевания COVID‑19 и тактика ведения
контактных лиц», опубл...кованных 17 марта 2020 г. Он
дополнен рекомендациями касательно организации ухода
на дому безопасным и надлежащим образом за
пациентами с заболеванием, вызванным новым
коронавирусом 2019 г. (COVID-19), а также
санитарно-эпидемиологических мер в отношении
контактных лиц. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts
more
A Technical Brief for Breakthrough ACTION Field Teams
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...f medicines’ benefit and harm help to achieve the ultimate goal of safe and effective treatments available to patients.
The guideline is intended to assist healthcare professionals in the reporting of suspected adverse drug reactions (ADRs) associated with the use of all registered health products, including medicines, old medicines, medical devices and in-vitro diagnostics (IVDs).
more